Céline Bellanger
Impact in
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
Papers in
-
- Protein Degradation and Inhibitors 3
- Ubiquitin and proteasome pathways 2
-
- Lymphoma Diagnosis and Treatment 7
- Co-authors
- Catherine Pellat‐Deceunynck (16 shared papers)Martine Amiot (9 shared papers)David Chiron (13 shared papers)Benoît Tessoulin (13 shared papers)Philippe Moreau (10 shared papers)Cyrille Touzeau (9 shared papers)Patricia Gomez‐Bougie (6 shared papers)Steven Le Gouill (8 shared papers)
- Journals
- Blood (7 papers)Leukemia (3 papers)Frontiers in Oncology (2 papers)Haematologica (2 papers)Blood Advances (1 paper)
- Partner nations
- FranceUnited StatesCanada
In The Last Decade
Céline Bellanger
18 papers receiving 329 citations
Peers
Comparison fields: 5 of 43
- Genetics 86
- Pathology and Forensic Medicine 108
- Hematology 67
- Oncology 116
- Immunology 85
Countries citing papers authored by Céline Bellanger
This map shows the geographic impact of Céline Bellanger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Bellanger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Bellanger more than expected).
Fields of papers citing papers by Céline Bellanger
This network shows the impact of papers produced by Céline Bellanger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Bellanger. The network helps show where Céline Bellanger may publish in the future.
Co-authors
The 25 scholars most cited alongside Céline Bellanger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 68 | |
| 2 | 2019 | 58 | |
| 3 | 2019 | 58 | |
| 4 | 2020 | 34 | |
| 5 | 2019 | 27 | |
| 6 | 2018 | 20 | |
| 7 | 2021 | 19 | |
| 8 | 2023 | 14 | |
| 9 | 2022 | 14 | |
| 10 | 2023 | 7 | |
| 11 | 2023 | 5 | |
| 12 | 2016 | 2 | |
| 13 | 2023 | 1 | |
| 14 | 2016 | 1 | |
| 15 | 2024 | 1 | |
| 16 | 2015 | 1 | |
| 17 | 2022 | 1 | |
| 18 | 2022 | 1 | |
| 19 | 2025 | 0 | |
| 20 | 2026 | 0 |
About Céline Bellanger
Céline Bellanger is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Oncology, Immunology and Hematology, having authored 21 papers that have together received 332 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (7 papers), Multiple Myeloma Research and Treatments (4 papers), Protein Degradation and Inhibitors (3 papers), HIV/AIDS drug development and treatment (3 papers), Immune Cell Function and Interaction (3 papers), CAR-T cell therapy research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Genetics (86 citations), Pathology and Forensic Medicine (108 citations), Hematology (67 citations), Oncology (116 citations) and Immunology (85 citations). Céline Bellanger has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Catherine Pellat‐Deceunynck, Martine Amiot, David Chiron, Benoît Tessoulin, Philippe Moreau, Cyrille Touzeau, Patricia Gomez‐Bougie, Steven Le Gouill, Sophie Maïga and Yannick Le Bris. Their work appears in journals such as Blood, Leukemia, Frontiers in Oncology, Haematologica and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.